Evidence map›Paper›PMID 36248759›Full record

ArticleEuropean journal of breast health2022

Gastrointestinal Tract Metastases of Invasive Lobular Carcinoma of the Breast: An Immunohistochemical Survey Algorithm.

Baha Zengel, Demet Çavdar, Özlem Özdemir, Funda Taşlı, Murat Karataş, Cenk Şimşek, Adam Uslu

Abstract readCase Reports
In one paragraph

Article in European journal of breast health, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Baha ZengelDepartment of General Surgery, University of Health Sciences Turkey, İzmir Bozyaka Health Practice and Research Center, İzmir, Turkey.ORCID https://orcid.org/0000-0002-1812-6846
Demet ÇavdarDepartment of Pathology, University of Health Sciences Turkey, İzmir Bozyaka Health Practice and Research Center, İzmir, Turkey.ORCID https://orcid.org/0000-0002-3278-3770
Özlem ÖzdemirDepartment of Medical Oncology, University of Health Sciences Turkey, İzmir Bozyaka Health Practice and Research Center, İzmir, Turkey.ORCID https://orcid.org/0000-0003-2520-5953
Funda TaşlıDepartment of Pathology, University of Health Sciences Turkey, İzmir Bozyaka Health Practice and Research Center, İzmir, Turkey.ORCID https://orcid.org/0000-0001-5145-0026
Murat KarataşDepartment of General Surgery, University of Health Sciences Turkey, İzmir Bozyaka Health Practice and Research Center, İzmir, Turkey.ORCID https://orcid.org/0000-0002-7957-9291
Cenk ŞimşekDepartment of General Surgery, University of Health Sciences Turkey, İzmir Bozyaka Health Practice and Research Center, İzmir, Turkey.ORCID https://orcid.org/0000-0002-9296-0097
Adam UsluDepartment of General Surgery, University of Health Sciences Turkey, İzmir Bozyaka Health Practice and Research Center, İzmir, Turkey.ORCID https://orcid.org/0000-0003-2697-472X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Invasive lobular carcinoma (ILC) accounts for almost 15% of all breast carcinomas. The potential of ILC to metastasize to the gastointestinal system is significantly greater than that of invasive ductal carcinoma. Gastric metastasis occurred in the ninth year of the follow-up in a patient who was operated on the right breast due to ILC. The patient was investigated for simultaneous masses in the stomach and colon, and a random mass was found in her right breast.

Indexed as

Breast cancercolonic metastasisgastric metastasisgastrointestinal tract metastasisinvasive lobular carcinoma

Identifiers

PMID36248759
PMCPMC9521291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.